Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-08-22 5:22 pm Purchase | 13G | NKGen Biotech Inc. NKGN | CFIC-2015 NV Family Investments LLC | 4,166,666 13.900% | 4,166,666 (New Position) | View |
| 2024-05-10 2:42 pm Sale | 13G | NKGen Biotech Inc. NKGN | METEORA CAPITAL LLC | 0 0.000% | -1,596,817 (Position Closed) | View |
| 2024-02-14 1:05 pm Purchase | 13G | NKGen Biotech Inc. NKGN | METEORA CAPITAL LLC | 1,596,817 7.300% | 1,596,817 (New Position) | View |
| 2024-02-14 06:28 am Sale | 13G | NKGen Biotech Inc. NKGN | Radcliffe Capital Management L.P. | 0 0.000% | -641,474 (Position Closed) | View |
| 2024-02-07 07:31 am Unchanged | 13G | NKGen Biotech Inc. NKGN | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | 0 (Unchanged) | View |
| 2023-12-19 1:41 pm Sale | 13D | NKGen Biotech Inc. NKGN | NKMAX Co. Ltd. | 12,917,057 53.180% | -2,453,576 (-15.96%) | View |
| 2023-10-10 5:01 pm Purchase | 13D | NKGen Biotech Inc. NKGN | NKMAX Co. Ltd. | 15,370,633 63.400% | 15,370,633 (New Position) | View |
| 2023-05-23 10:29 am Purchase | 13G | NKGen Biotech Inc. NKGN | Radcliffe Capital Management L.P. | 641,474 6.180% | 641,474 (New Position) | View |
| 2023-01-25 07:09 am Sale | 13G | NKGen Biotech Inc. NKGN | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 0 0.000% | -1,124,431 (Position Closed) | View |
| 2022-02-11 4:10 pm Purchase | 13G | NKGen Biotech Inc. NKGN | Graf Acquisition Partners IV LLC | 4,210,375 19.600% | 4,210,375 (New Position) | View |
| 2022-02-03 08:19 am Purchase | 13G | NKGen Biotech Inc. NKGN | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,124,431 5.240% | 19,784 (+1.79%) | View |
| 2021-07-09 4:49 pm Purchase | 13G | NKGen Biotech Inc. NKGN | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,104,647 5.150% | 1,104,647 (New Position) | View |
| 2021-06-04 4:05 pm Purchase | 13G | NKGen Biotech Inc. NKGN | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,350,000 6.990% | 1,350,000 (New Position) | View |